These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 21494268

  • 1. Overcoming hurdles in developing successful drugs targeting chemokine receptors.
    Schall TJ, Proudfoot AE.
    Nat Rev Immunol; 2011 May; 11(5):355-63. PubMed ID: 21494268
    [Abstract] [Full Text] [Related]

  • 2. The clinical potential of chemokine receptor antagonists.
    Ribeiro S, Horuk R.
    Pharmacol Ther; 2005 Jul; 107(1):44-58. PubMed ID: 15894378
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Chemokine: receptor structure, interactions, and antagonism.
    Allen SJ, Crown SE, Handel TM.
    Annu Rev Immunol; 2007 Jul; 25():787-820. PubMed ID: 17291188
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Latest update on chemokine receptors as therapeutic targets.
    Lai WY, Mueller A.
    Biochem Soc Trans; 2021 Jun 30; 49(3):1385-1395. PubMed ID: 34060588
    [Abstract] [Full Text] [Related]

  • 11. Chemokine inhibition in inflammatory arthritis.
    Tak PP.
    Best Pract Res Clin Rheumatol; 2006 Oct 30; 20(5):929-39. PubMed ID: 16980215
    [Abstract] [Full Text] [Related]

  • 12. Anti-inflammatory drug development: Broad or specific chemokine receptor antagonists?
    Russo RC, Garcia CC, Teixeira MM.
    Curr Opin Drug Discov Devel; 2010 Jul 30; 13(4):414-27. PubMed ID: 20597027
    [Abstract] [Full Text] [Related]

  • 13. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.
    Chen X, Oppenheim JJ, Howard OM.
    Cell Mol Immunol; 2004 Oct 30; 1(5):336-42. PubMed ID: 16285892
    [Abstract] [Full Text] [Related]

  • 14. Chemokines and chemokine receptors in rheumatoid arthritis.
    Szekanecz Z, Kim J, Koch AE.
    Semin Immunol; 2003 Feb 30; 15(1):15-21. PubMed ID: 12495637
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Targeting cell migration in rheumatoid arthritis.
    Asquith DL, Bryce SA, Nibbs RJ.
    Curr Opin Rheumatol; 2015 Mar 30; 27(2):204-11. PubMed ID: 25603038
    [Abstract] [Full Text] [Related]

  • 18. CCR1 antagonists in clinical development.
    Pease JE, Horuk R.
    Expert Opin Investig Drugs; 2005 Jul 30; 14(7):785-96. PubMed ID: 16022568
    [Abstract] [Full Text] [Related]

  • 19. Chemokine receptors: multifaceted therapeutic targets.
    Proudfoot AE.
    Nat Rev Immunol; 2002 Feb 30; 2(2):106-15. PubMed ID: 11910892
    [Abstract] [Full Text] [Related]

  • 20. Chemokine receptor antagonists from discovery to the clinic.
    Horuk R.
    Ernst Schering Res Found Workshop; 2004 Feb 30; (44):169-90. PubMed ID: 14579780
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.